Girentuximab bringt keinen klinischen Benefit

[Article in German]

No authors listed

Comment

[Article in German]

No authors listed. Aktuelle Urol. 2017 Sep.

. 2017 Sep;48(5):419.

doi: 10.1055/s-0043-118396. Epub 2017 Aug 30.

No abstract available

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial.
Chamie K, Donin NM, Klöpfer P, Bevan P, Fall B, Wilhelm O, Störkel S, Said J, Gambla M, Hawkins RE, Jankilevich G, Kapoor A, Kopyltsov E, Staehler M, Taari K, Wainstein AJA, Pantuck AJ, Belldegrun AS. Chamie K, et al. JAMA Oncol. 2017 Jul 1;3(7):913-920. doi: 10.1001/jamaoncol.2016.4419. JAMA Oncol. 2017. PMID: 27787547 Free PMC article. Clinical Trial.